Vibe Bioscience Ltd (TSE:VIBE)
Canadian Market

Vibe Bioscience Ltd (VIBE) Income Statement


Vibe Bioscience Ltd Income Statement

Last quarter (Q2 2022), Vibe Bioscience Ltd's total revenue was $5.73M, a decrease of -26.48% from the same quarter last year. In Q2, Vibe Bioscience Ltd's net income was $-654.51K. See Vibe Bioscience Ltd’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 21Dec 20Dec 19Jul 18Jul 17
Total Revenue
$ 25.35M$ 29.29M$ 24.24M$ 12.60M$ 0.00$ 0.00
Cost of Revenue
$ 17.76M$ 20.87M$ 15.70M$ 7.98M--
Gross Profit
$ 7.60M$ 8.42M$ 8.54M$ 4.62M--
Operating Expense
$ 9.92M$ 8.92M$ 6.52M$ 6.66M$ 340.45K$ 309.51K
Operating Income
$ -2.32M$ -499.75K$ 2.02M$ -2.04M$ -340.45K$ -309.51K
Net Non Operating Interest Income Expense
$ -192.51K$ -203.44K$ -147.38K$ -132.61K$ -1.84K$ -1.93K
Other Income Expense
$ -1.78M$ -1.81M$ 546.60K$ -5.75M$ -1.21M$ 107.22K
Pretax Income
$ -4.29M$ -2.51M$ 2.42M$ -7.92M$ -1.55M$ -204.21K
Tax Provision
$ 1.62M$ 1.79M$ 1.69M$ 697.16K--
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ -5.91M$ -4.30M$ 728.55K$ -8.62M$ -1.55M$ -204.21K
Basic EPS
$ -0.06$ -0.04$ 0.01$ -0.11$ -0.74$ -0.10
Diluted EPS
$ -0.06$ -0.04$ 0.01$ -0.11$ -0.74$ -0.10
Basic Average Shares
$ 431.35M$ 99.09M$ 79.19M$ 76.05M$ 2.20M$ 2.08M
Diluted Average Shares
$ 431.35M$ 99.09M$ 83.16M$ 76.05M$ 2.20M$ 2.08M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
$ 27.67M$ 29.79M$ 22.22M$ 14.64M$ 340.45K$ 309.51K
Interest Expense
$ 192.51K$ 203.44K$ 147.38K$ 132.61K$ 1.84K$ 1.93K
Net Income From Continuing And Discontinued Operation
$ -5.91M$ -4.30M$ 728.55K$ -8.62M$ -1.55M$ -204.21K
Normalized Income
$ -4.74M$ -3.10M$ 503.38K$ -4.64M$ -308.93K$ -200.20K
$ -4.10M$ -2.31M$ 2.57M$ -7.79M$ -1.55M$ -202.28K
$ -2.59M$ -1.11M$ 3.36M$ -6.95M$ -1.55M$ -202.28K
Currency in USD

Vibe Bioscience Ltd Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis